Hjem › Follikulært lymfom › Ohio › Columbus
Kliniske studier for Follikulært lymfom i Columbus, OH
13 studier for Follikulært lymfom søker deltakere på steder i og rundt Columbus (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RekruttererFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Epco, Zanu, Ritux for R/R FL or MZL
RekruttererFase 2
- The Ohio State University Wexner Medical Center, Columbus
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekruttererFase 1
- The Ohio State University (OSU), Columbus
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
RekruttererFase 3
- Research Site, Columbus
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
RekruttererFase 2
- Research Site, Columbus
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
RekruttererObservasjonsstudie
- OhioHealth Research Institute, Columbus
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RekruttererFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruttererFase 1/2
- The Ohio State University Wexner Medical Center, Columbus
Epcoritamab and Rituximab for First-line Follicular Lymphoma
RekruttererFase 2
- The Ohio State University Wexner Medical Center, Columbus
Study of SGR-1505 in Mature B-Cell Neoplasms
RekruttererFase 1
- The Ohio State University - The James Cancer Hospital, Columbus
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
RekruttererFase 1
- Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Columbus
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekruttererFase 1
- The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Follikulært lymfom-studier i andre byer
- New York City, NY24 studier
- Milwaukee, WI19 studier
- Nashville, TN18 studier
- Houston, TX18 studier
- Boston, MA17 studier
- Baldwin Park, CA16 studier
- Seattle, WA15 studier
- Durham, NC15 studier
- Salt Lake City, UT13 studier
- San Antonio, TX12 studier
- Chicago, IL12 studier
- Philadelphia, PA12 studier
Andre studier i Columbus
- Ikke-småcellet lungekreft56 studier
- Brystkreft39 studier
- Eggstokkreft39 studier
- Kreft (alle typer)38 studier
- Lungekreft37 studier
- Akut myelogen leukemi35 studier
- Kronisk lymfatisk leukemi28 studier
- Metastatisk kreft27 studier
- Endometriekreft25 studier
- Kolorektal kreft24 studier
- Prostatakreft24 studier
- Multipelt myelom24 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.